Biochemical Pharmacology volume 82, issue 2, P91-98 2011 DOI: 10.1016/j.bcp.2011.03.015 View full text
|
|
Share
Robert G. Schaub

Abstract: Hemophilia is a family of rare bleeding disorders. The two primary types, hemophilia A and hemophilia B, are caused by recessive X-chromosome linked mutations that result in deficiency of coagulation factor VIII (FVIII) or factor IX (FIX), respectively. Clinically, hemophilia is manifested by spontaneous bleeding, particularly into the joints (haemarthrosis) and soft tissue, and excessive bleeding following trauma or surgery. The total overall number of hemophilia patients worldwide is approximately 400,000, h…

expand abstract